Table 1 Basic characteristics of the patients
Categories | N (%) | Mean age in years (SD) | Sex Women (%) | Mean HbA1c f (%) | Mean LDL g (mmol/l) | |||
|---|---|---|---|---|---|---|---|---|
2011-12 (SD) | 2015-16 (SD) | 2011-12 (SD) | 2015-16 (SD) | |||||
Patient groups a | ||||||||
T2D only | 4440 | (53) | 64 (10.9) | 48 | 6.5 (1.11) | 6.8 (1.22) | 2.6 (0.81) | 2.5 (0.85) |
T2D + CVD | 2544 | (30) | 71 (9.41) | 39 | 6.7 (1.14) | 7.0 (1.25) | 2.3 (0.77) | 2.1 (0.82) |
T2D + AMD | 942 | (11) | 60 (12.6) | 61 | 6.6 (1.31) | 6.8 (1.35) | 2.6 (0.84) | 2.5 (0.93) |
T2D + CVD + AMD | 503 | (6) | 70 (11.7) | 55 | 6.7 (1.26) | 7.1 (1.41) | 2.4 (0.87) | 2.3 (0.87) |
Glucose lowering medication b | ||||||||
No medication | 627 | (7) | 68 (12.6) | 52 | 5.7 (0.35) | 5.8 (0.37) | 2.8 (0.89) | 2.6 (1.00) |
Metformin only | 2009 | (24) | 65 (10.9) | 52 | 5.8 (0.38) | 6.1 (0.53) | 2.5 (0.81) | 2.4 (0.84) |
Metformin and/or other non-insulin medication | 1317 | (16) | 66 (10.5) | 46 | 6.3 (0.67) | 6.6 (0.85) | 2.5 (0.77) | 2.4 (0.82) |
Combination of insulin and non-insulin medication | 1810 | (21) | 65 (11.0) | 42 | 7.5 (1.30) | 7.7 (1.33) | 2.4 (0.79) | 2.2 (0.82) |
Only insulin therapy | 329 | (4) | 69 (12.0) | 43 | 7.5 (1.43) | 7.7 (1.48) | 2.5 (0.86) | 2.3 (0.96) |
Medication changed c | 2337 | (28) | 66 (12.0) | 46 | 6.5 (1.03) | 6.9 (1.19) | 2.6 (0.84) | 2.4 (0 89) |
Lipid lowering medication d | ||||||||
No therapy | 1869 | (22) | 64 (13.7) | 51 | 6.5 (1.17) | 6.8 (1.22) | 2.8 (0.71) | 2.8 (0.74) |
Low intensity | 467 | (6) | 71 (10.4) | 60 | 6.5 (0.98) | 6.9 (1.29) | 2.2 (0.63) | 2.2 (0.64) |
Moderate intensity | 3740 | (44) | 66 (10.5) | 45 | 6.6 (1.11) | 6.9 (1.20) | 2.3 (0.77) | 2.2 (0.80) |
High intensity | 633 | (8) | 65 (9.45) | 33 | 6.7 (1.20) | 7.0 (1.32) | 2.4 (0.82) | 2.2 (0.91) |
Medication changed e | 1720 | (20) | 66 (10.9) | 47 | 6.6 (1.27) | 7.0 (1.29) | 2.8 (0.86) | 2.5 (0.99) |